| Literature DB >> 28473760 |
Tove Porseryd1, Kristina Volkova1,2, Nasim Reyhanian Caspillo1,2, Thomas Källman3,4, Patrik Dinnetz1, Inger Porsh Hällström1.
Abstract
The synthetic estrogen 17α-ethinylestradiol (EE2) is an endocrine disrupting compound of concern due to its persistence and widespread presence in the aquatic environment. Effects of developmental exposure to low concentrations of EE2 in fish on reproduction and behavior not only persisted to adulthood, but have also been observed to be transmitted to several generations of unexposed progeny. To investigate the possible biological mechanisms of the persistent anxiogenic phenotype, we exposed zebrafish embryos for 80 days post fertilization to 0, 3, and 10 ng/L EE2 (measured concentrations 2.14 and 7.34 ng/L). After discontinued exposure, the animals were allowed to recover for 120 days in clean water. Adult males and females were later tested for changes in stress response and shoal cohesion, and whole-brain gene expression was analyzed with RNA sequencing. The results show increased anxiety in the novel tank and scototaxis tests, and increased shoal cohesion in fish exposed during development to EE2. RNA sequencing revealed 34 coding genes differentially expressed in male brains and 62 in female brains as a result of EE2 exposure. Several differences were observed between males and females in differential gene expression, with only one gene, sv2b, coding for a synaptic vesicle protein, that was affected by EE2 in both sexes. Functional analyses showed that in female brains, EE2 had significant effects on pathways connected to the circadian rhythm, cytoskeleton and motor proteins and synaptic proteins. A large number of non-coding sequences including 19 novel miRNAs were also differentially expressed in the female brain. The largest treatment effect in male brains was observed in pathways related to cholesterol biosynthesis and synaptic proteins. Circadian rhythm and cholesterol biosynthesis, previously implicated in anxiety behavior, might represent possible candidate pathways connecting the transcriptome changes to the alterations to behavior. Further the observed alteration in expression of genes involved in synaptogenesis and synaptic function may be important for the developmental modulations resulting in an anxiety phenotype. This study represents an initial survey of the fish brain transcriptome by RNA sequencing after long-term recovery from developmental exposure to an estrogenic compound.Entities:
Keywords: 17α-ethinylestradiol; RNA sequencing; brain transcriptome; developmental exposure; endocrine disrupting compounds; persistent effects; stress behavior; zebrafish
Year: 2017 PMID: 28473760 PMCID: PMC5397488 DOI: 10.3389/fnbeh.2017.00069
Source DB: PubMed Journal: Front Behav Neurosci ISSN: 1662-5153 Impact factor: 3.558
Primer sequences used for qPCR analyses.
| 18S r RNA | 5′-AATGTCTGCCCTATCAACTTTC-′3 |
| 3′-TGGATGTGGTAGCCGTTTC-′5 | |
| Elf1a | 5′-TACCCTCCTCTTGGTCGCTTT-′3 |
| 3′-ACCTTTGGAACGGTGTGATTG-′5 | |
| Msmo1 | 5′-TCAGCATCCCTTATGACTGG-′3 |
| 3′-AATGGAGAAGTGAAGTCGTGA-′5 | |
| Sqlea | 5′-ACAGCTACCAGAGCACTTAAA-′3 |
| 3′-CGCATGTTATACGCATCTCC-′5 | |
| Lss | 5′-TACAAGCATTTCTTGAGGCAG-′3 |
| 3′-CAGTCAGCAACTATCCAACC-′5 | |
| Hmgcs1 | 5′-CGCTGCTACACTTTACTCCA-′3 |
| 3′-TAGTTTGCTAAATGGTGGGTTTC-′5 |
Filby and Tyler, .
Designed by Primer-BLAST primer designing tool.
Bodyweight, hepatosomatic index (HSI), and gonadosomatic index (GSI) in male and female zebra fish developmentally exposed to EE.
| Bodyweight (log) | 4.852 | 0.0884 | |||||
| Controls | 16 | 0.393 | 0.018 | ||||
| 3 ng/L | 15 | 0.367 | 0.013 | − | |||
| 10 ng/L | 16 | 0.421 | 0.018 | − | |||
| HSI (log) | 9.096 | 0.0106 | |||||
| Controls | 14 | 0.709 | 0.111 | ||||
| 3 ng/L | 15 | 0.875 | 0.129 | 0.221 | |||
| 10 ng/L | 16 | 1.005 | 0.101 | 0.0071 | |||
| GSI (log) | 10.05 | 0.0066 | |||||
| Controls | 16 | 1.558 | 0.222 | ||||
| 3 ng/L | 15 | 1.028 | 0.122 | 0.0117 | |||
| 10 ng/L | 16 | 1.51 | 0.224 | 0.9750 | |||
| Bodyweight (log) | 1.433 | 0.4886 | |||||
| Controls | 16 | 0.616 | 0.036 | ||||
| 3 ng/L | 16 | 0.619 | 0.038 | − | |||
| 10 ng/L | 14 | 0.731 | 0.095 | − | |||
| HSI (log) | 0.489 | 0.783 | − | ||||
| Controls | 15 | 2.01 | 0.298 | − | |||
| 3 ng/L | 16 | 1.818 | 0.201 | − | |||
| 10 ng/L | 14 | 2.115 | 0.234 | − | |||
| GSI (log) | − | ||||||
| Controls | 16 | 12.08 | 1.168 | 2.871 | 0.238 | − | |
| 3 ng/L | 16 | 19.86 | 6.163 | − | |||
| 10 ng/L | 14 | 14.60 | 1.866 | − | |||
p < 0.05;
p < 0.01.
Figure 1Novel tank behavior in male and female zebrafish developmentally exposed to 0, 3, or 10 ng/L EE Latency time before crossing the horizontal midline to the upper half. (B) Number of transitions to upper half and (C) Total time spent in upper half. Data represent mean ± 95% CI, #p < 0.05, *p < 0.05, **p < 0.01. *Significantly different from control fishes of the same sex, #control females significantly different from control males.
Results from behavior tests with mixed effects models following Tukey multiple comparison test when significant treatment effect. Treatment vs. controls analyzed with Tukey contrasts.
| Latency to upper half | 7.78 | 0.021 | 45.05 | <0.001 | 7.48 | 0.024 | |||
| Controls | 78 | ||||||||
| 3 ng/L | 79 | 0.139 | |||||||
| 10 ng/L | 78 | 0.022 | |||||||
| Total transitions (log) | 1.505 | 0.471 | 48.29 | <0.001 | 14.17 | <0.001 | |||
| Controls | 78 | ||||||||
| 3 ng/L | 79 | − | |||||||
| 10 ng/L | 78 | − | |||||||
| Total time in upper half | 13.77 | 0.001 | 12.77 | <0.001 | 3.39 | 0.183 | |||
| Controls | 78 | ||||||||
| 3 ng/L | 79 | 0.008 | |||||||
| 10 ng/L | 78 | <0.001 | |||||||
| Latency to opposite half | 0.482 | 0.79 | 16.35 | <0.001 | 1.84 | 0.40 | |||
| Controls | 57 | ||||||||
| 3 ng/L | 58 | − | |||||||
| 10 ng/L | 51 | − | |||||||
| Total transitions | 24.80 | <0.001 | 202.48 | <0.001 | 1.94 | 0.40 | |||
| Controls | 57 | ||||||||
| 3 ng/L | 58 | <0.001 | |||||||
| 10 ng/L | 51 | <0.001 | |||||||
| Time in opposite half | 1.45 | 0.49 | 45.38 | <0.001 | 2.70 | 0.26 | |||
| Controls | 57 | ||||||||
| 3 ng/L | 58 | − | |||||||
| 10 ng/L | 51 | − | |||||||
| Latency to cross (log) | 5.74 | 0.057 | 21.32 | <0.001 | 0.77 | 0.68 | |||
| Controls | 69 | ||||||||
| 3 ng/L | 68 | − | |||||||
| 10 ng/L | 79 | − | |||||||
| Total transitions (log) | 13.03 | 0.0015 | 77.14 | <0.001 | 46.23 | <0.001 | |||
| Controls | 69 | ||||||||
| 3 ng/L | 68 | <0.001 | |||||||
| 10 ng/L | 79 | 0.662 | |||||||
| Time in white zone (log) | 6.16 | 0.046 | 7.0 | 0.0008 | 9.28 | 0.0097 | |||
| Controls | 69 | ||||||||
| 3 ng/L | 68 | 0.02 | |||||||
| 10 ng/L | 79 | 0.88 | |||||||
Analyses include zebra fish males and females treated with EE.
p < 0.05,
p < 0.01,
p < 0.001.
Figure 2Shoaling behavior in male and female zebrafish developmentally exposed to 0, 3, or 10 ng/L EE Latency time before leaving shoal (crossing the vertical midline), (B) Number of transitions to the opposite half and (C) Total time spent in the opposite half. Data represent mean ± 95% CI, #p < 0.05, ***p < 0.001. *Significantly different from control fishes of the same sex, #control females significantly different from control males.
Figure 3Scototaxis behavior in male and female zebrafish developmentally exposed to 0, 3, or 10 ng/L EE Latency time before entering the white half, (B) Number of transitions to the white half, and (C) Total time spent in the white half. Data represent mean ± 95% CI, #p < 0.05, *p < 0.05, **p < 0.01, ***p < 0.001. *Significantly different from control fishes of the same sex, #control females significantly different from control males.
List of protein coding genes significantly affected in brains of female zebrafish developmentally exposed to 10ng/L EE.
| ENSDARG00000057652 | dbpb | 0.92 | 6.82 | <0.001 | <0.001 | Regulation of transcription (DNA templated), sequence-specific DNA binding | DBP |
| ENSDARG00000033160 | nr1d1 | 2.21 | 5.98 | <0.001 | <0.001 | Regulation of transcription (DNA templated), Sequence-specific DNA binding, steroid and thyroid hormone receptor activity | NR1D1 |
| ENSDARG00000056885 | per1a | 1.83 | 6.24 | <0.001 | <0.001 | Photoperiodism, signal transduction, response to hydrogen peroxide | PER1 |
| ENSDARG00000058094 | CIART (1 of 2) | 1.99 | 5.54 | <0.001 | 0.003 | Not available | CIART |
| ENSDARG00000088171 | CIART (2 of 2) | 0.81 | 6.21 | <0.001 | 0.03 | Not available | CIART |
| ENSDARG00000075397 | cipca | 1.65 | 3.91 | <0.001 | 0.004 | Not available | CIPC |
| ENSDARG00000041691 | bhlhe41 | 1.01 | 7.83 | <0.001 | 0.028 | Negative regulation of transcription (DNA templated), protein dimerization, DNA binding | BHLHE41 |
| ENSDARG00000068468 | DNAH3 | −1.51 | 5.26 | <0.001 | <0.001 | Not available | DNAH3 |
| ENSDARG00000056888 | DNAH8 | −1.86 | 6.06 | <0.001 | <0.001 | Not available | Unknown |
| ENSDARG00000041723 | zgc:55461 | −1.48 | 4.72 | <0.001 | 0.002 | Protein polymerization, microtubule-based process, GTP binding, nucleotide binding | TUBB4A/TUBB4B |
| ENSDARG00000042708 | tuba8l | −0.90 | 4.58 | <0.001 | 0.036 | Microtubule-based process, protein polymerization, GTP binding, nucleotide binding | TUBA8 |
| ENSDARG00000087352 | AL935046.1 | −1.38 | 5.07 | <0.001 | 0.037 | Not available | DNAH2 |
| ENSDARG00000001993 | myhb | 1.67 | 3.53 | <0.001 | 0.039 | Motor activity, ATP binding, actin binding, Myosin complex | MYH1/13/2/8/4 |
| ENSDARG00000059987 | dnah12 | −1.10 | 3.88 | <0.001 | 0.045 | Microtubule-based movement, microtubule motor activity | DNAH12 |
| ENSDARG00000040528 | Igals3bpb | 1.17 | 5.37 | <0.001 | <0.001 | Cell adhesion, scavenger receptor activity | LGALS3BP |
| ENSDARG00000026611 | socs3b | −1.21 | 4.43 | <0.001 | <0.001 | JAK-STAT cascade, protein kinase inhibitor activity | SOCS3 |
| ENSDARG00000053136 | b2m | −0.80 | 6.69 | <0.001 | 0.001 | Immune system process, MHCI protein complex | B2M |
| ENSDARG00000079412 | ftr02 | −3.20 | 1.39 | <0.001 | 0.004 | Metal ion binding, zinc ion binding | TRIM29 |
| ENSDARG00000060711 | SV2B | −1.21 | 4.89 | <0.001 | 0.013 | Not available | SV2B |
| ENSDARG00000074749 | abca12 | −3.08 | 2.93 | <0.001 | <0.001 | Lipid transport, cholesterol efflux, phospholipid transporter activity | ABCA12 |
| ENSDARG00000039406 | prom2 | −1.96 | 4.03 | <0.001 | 0.003 | Integral component of membrane | PROM2 |
| ENSDARG00000040295 | apoeb | −1.12 | 7.78 | <0.001 | 0.03 | Lipid transport, cholesterol biosynthetic process, negative regulation of neuron apoptotic process | APOE |
| ENSDARG00000003462 | fech | −0.94 | 5.67 | <0.001 | <0.001 | Erythrocyte maturation, heme biosynthetic process, ferrochelatase activity | FECH |
| ENSDARG00000031952 | mb | 3.13 | 3.31 | <0.001 | 0.002 | Vasculogenesis, oxygen transport, response to hypoxia, oxygen binding, heme binding | MB |
| ENSDARG00000055101 | hmox2a | −0.72 | 5.41 | <0.001 | 0.008 | Hemeoxygenase (decyclizing) activity, oxidation-reduction process, heme oxidation | HMOX2 |
| ENSDARG00000078529 | Bai1b | 0.82 | 8.61 | <0.001 | 0.04 | Regulation of angiogenesis | BAI1 |
| ENSDARG00000089195 | pcdh2g20 | −1.90 | 2.10 | <0.001 | 0.02 | Cell adhesion, calcium ion binding | Unknown |
| ENSDARG00000014047 | cldn7b | −2.32 | 2.87 | <0.001 | 0.04 | Structural molecular activity | CLDN7 |
| ENSDARG00000092933 | cbx8a | −4.59 | 1.32 | <0.001 | <0.001 | Nucleus | CBX8 |
| ENSDARG00000060645 | sirt7 | −1.34 | 4.49 | <0.001 | 0.004 | NAD+ binding | SIRT7 |
| ENSDARG00000051970 | smu1b | 1.21 | 6.44 | <0.001 | 0.010 | Not available | SMU1 |
| ENSDARG00000063572 | perp | −0.91 | 5.07 | <0.001 | 0.015 | Regulation of apoptotic process, response to UV | PERP |
| ENSDARG00000020084 | tg | −2.62 | 1.93 | <0.001 | 0.004 | Carboxylic ester hydrolase activity | TG |
| ENSDARG00000002494 | itgb6 | −2.29 | 1.70 | <0.001 | 0.018 | Integrin-mediated signaling pathway, cell adhesion, receptor activity | ITGB6 |
| ENSDARG00000016470 | anxa5b | −2.15 | 3.06 | <0.001 | 0.02 | Negative regulation of coagulation, regulation of cell motility, calcium-dependent phospholipid binding | ANXA5 |
| ENSDARG00000026611 | socs3b | −1.21 | 4.43 | <0.001 | <0.001 | JAK-STAT cascade, protein kinase inhibitor activity | SOCS3 |
| ENSDARG00000092115 | eif4a1a | −1.18 | 8.96 | <0.001 | <0.01 | Translational initiation, nucleotide binding, ATP binding, helicase activity, hydrolase activity | SENP3, EIF4A1 |
| ENSDARG00000091245 | dnajc7 | −1.22 | 4.84 | <0.001 | <0.001 | Not available | DNAJC7 |
| ENSDARG00000009978 | icn | −1.91 | 4.54 | <0.001 | 0.03 | Calcium ion binding | S100A2/3/4/5/6 |
| ENSDARG00000069476 | spint2 | −3.43 | 3.45 | <0.001 | 0.01 | Serine-type endopeptidase inhibitor activity | SPINT2 |
| ENSDARG00000024195 | znf395b | 0.95 | 5.74 | <0.001 | 0.01 | Metal ion binding | ZNF395 |
| ENSDARG00000068923 | unmodl1 | −2.20 | 2.49 | <0.001 | 0.019 | Peptidase inhibitor activity, calcium ion binding | UMODL1 |
| ENSDARG00000075984 | hsbp1l1 | −2.53 | 1.34 | <0.001 | 0.025 | Not available | HSBP1 |
| ENSDARG00000038729 | s100z | −1.53 | 2.97 | <0.001 | 0.038 | Metal ion binding, calcium binding | S100Z |
| ENSDARG00000074807 | tbrg4 | −0.75 | 4.65 | <0.001 | 0.048 | Protein kinase activity | TBRG4 |
| ENSDARG00000052012 | rtn4rl2a | 1.09 | 5.51 | <0.001 | 0.042 | Not available | RTN4RL2 |
| ENSDARG00000089382 | zgc:158463 | −3.63 | 7.93 | <0.001 | <0.001 | Not available | Unknown |
| ENSDARG00000088436 | CT956064.3 | −3.58 | 5.84 | <0.001 | <0.001 | Not available | Unknown |
| ENSDARG00000091744 | BX296557.7 | −2.97 | 7.17 | <0.001 | <0.001 | Not available | Unknown |
| ENSDARG00000031588 | si:dkey-239b22.1 | −4.22 | 3.44 | <0.001 | <0.001 | Cell-matrix adhesion | Unknown |
| ENSDARG00000068374 | si:ch211-132b12.7 | 1.50 | 6.56 | <0.001 | <0.001 | Not available | Unknown |
| ENSDARG00000091234 | CU019646.2 | −2.25 | 2.30 | <0.001 | 0.001 | Not available | Unknown |
| ENSDARG00000067703 | NLRP | 1.32 | 4.62 | <0.001 | 0.0037 | Not available | Unknown |
| ENSDARG00000079175 | si:ch211-79k12.1 | −2.44 | 2.44 | <0.001 | 0.004 | Not available | Unknown |
| ENSDARG00000088142 | Unknown | 1.72 | 4.74 | <0.001 | 0.004 | Not available | Unknown |
| ENSDARG00000087067 | CABZ01073069.1 | 3.73 | 0.84 | <0.001 | 0.007 | Not available | Unknown |
| ENSDARG00000088938 | BX548011.4 | −3.12 | 1.34 | <0.001 | 0.008 | Not available | Unknown |
| ENSDARG00000036700 | Unknown | −1.71 | 5.00 | <0.001 | <0.01 | Not available | Unknown |
| ENSDARG00000093780 | si:ch211-212c13.6 | −2.42 | 3.63 | <0.001 | <0.01 | Not available | Unknown |
| ENSDARG00000042829 | si:dkey-30j22.1 | −2.46 | 3.73 | <0.001 | 0.019 | Calcium ion binding, extracellular matrix structural constituent | Unknown |
| ENSDARG00000070212 | zgc:158463 | −1.69 | 9.23 | <0.001 | 0.03 | Not available | Unknown |
| ENSDARG00000080675 | si:dkey-71b5.7 | −2.71 | 3.70 | <0.001 | 0.019 | Not available | Unknown |
| ENSDARG00000090930 | si:ch211-120g10.1 | −1.93 | 4.54 | <0.001 | <0.001 | Not available | Unknown |
This gene is assosciated with multiple categories LogFC, Log fold change; Log CPM, Log count per million; FDR, False discovery rate. Human orthologs were found in Ensembl and categories assigned manually based on information available on Entrez gene, NGNC, and Omim databases. GO-terms were found in Zfin.
List of protein coding genes significantly affected in brains of male zebrafish developmentally exposed to 3ng/L EE.
| ENSDARG00000052738 | hmgcs1 | 1.01 | 5.75 | <0.001 | 0.01 | Oligodendrocyte development, isoprenoid biosynthetic process | HMGCS1 |
| ENSDARG00000079946 | sqlea | 1.84 | 4.21 | <0.001 | 0.01 | Fatty acid biosynthesis process, metabolic process, oxidation reduction process, 3-hydroxyacyl-CoA dehydrogenase activity, flavin adenine dinucleotide binding, oxidoreductase activity, squalene monooxygenase activity | SQLE |
| ENSDARG00000061274 | lss | 1.34 | 3.95 | <0.001 | 0.02 | Baruol synthase activity | LSS |
| ENSDARG00000055876 | msmo1 | 0.98 | 5.08 | <0.001 | 0.01 | Fatty acid biosynthesis process, endoplasmic reticulum, C-4 methylsterol oxidase activity | MSMO1 |
| ENSDARG00000060711 | SV2B | 0.86 | 5.25 | <0.001 | 0.01 | Not available | SV2B |
| ENSDARG00000090540 | Svbb | −0.68 | 5.47 | <0.001 | 0.02 | Transmembrane transport, integral component of membrane, transmembrane transporter activity | SV2B |
| ENSDARG00000078624 | arhgef9b | −1.05 | 5.27 | <0.001 | 0.005 | Regulation of Rho protein signal transduction, Rho guanyl-nucleotide exchange factor activity | ARHGEF9 |
| ENSDARG00000079015 | brca2 | 1.20 | 4.02 | <0.001 | 0.01 | DNA repair, regulation of transcription, female gonad development, spermatogenesis, centrosome, γ-tubulin binding | BRCA2 |
| ENSDARG00000055754 | smc1a | 1.01 | 6.22 | <0.001 | 0.01 | DNA repair, chromosome organization, ATP binding, chromatin binding | SMC1A |
| ENSDARG00000024877 | ptgr1 | −2.32 | 4.24 | <0.001 | 0.015 | Oxidation-reduction process, oxidoreductase activity, zinc ion binding | PTGR1 |
| ENSDARG00000070396 | serpinb1l2 | 5.71 | 1.11 | <0.001 | <0.001 | Negative regulation of endopeptidase activity, extracellular space, serine-type endopeptidase activity | SERPINB1 |
| ENSDARG00000070449 | tspan5b | −2.02 | 2.88 | <0.001 | 0.002 | Integral component of membrane | TSPAN5 |
| ENSDARG00000097011 | hbaa1 | 1.48 | 6.56 | <0.001 | 0.005 | Response to hypoxia, hemoglobin complex, heme binding | HBA1 |
| ENSDARG00000069735 | si:ch211-5k11.6 | 2.79 | 2.01 | <0.001 | 0.008 | Oxygen transport, hemoglobin complex, heme binding | Unknown |
| ENSDARG00000078322 | col12a1a | 0.94 | 5.00 | <0.001 | 0.019 | Collagen trimer | COL12A1 |
| ENSDARG00000033760 | pmelb | 1.90 | 2.62 | <0.001 | 0.005 | Not available | PMEL |
| ENSDARG00000087678 | rbm22 | 2.46 | 1.52 | <0.001 | 0.04 | RNA splicing, multicellular organismal development | RBM22 |
| ENSDARG00000022185 | RGL3 | −1.58 | 2.51 | <0.001 | 0.03 | Not available | RGL3 |
| ENSDARG00000086838 | ITGA2 | −3.48 | 1.33 | <0.001 | 0.007 | Not available | ITGA2 |
| ENSDARG00000078624 | arhgef9b | −1.05 | 5.27 | <0.001 | 0.005 | Regulation of Rho protein signal transduction, Rho guanyl-nucleotide exchange factor activity | ARHGEF9 |
| ENSDARG00000092281 | flnb | −0.93 | 4.35 | <0.001 | 0.04 | Not available | FLNB |
| ENSDARG00000009524 | rnf150b | 0.63 | 7.20 | <0.001 | 0.01 | Metal ion binding, zinc ion binding | RNF150 |
| ENSDARG00000077799 | EGR4 | 1.22 | 5.50 | <0.001 | 0.015 | Not available | EGR4 |
| ENSDARG00000041294 | noxo1a | −2.65 | 1.36 | <0.001 | 0.002 | Phosphatidylinositol binding | NOXO1 |
| ENSDARG00000042988 | SLC24A2 (1 of 2) | −3.50 | 2.95 | <0.001 | 0.009 | Not available | SLC24A2 |
| ENSDARG00000058508 | CFAP70 | −2.48 | 4.29 | <0.001 | 0.01 | Not available | CFAP70 |
| ENSDARG00000094587 | si:dkey-35m8.1 | −0.87 | 4.67 | <0.001 | 0.017 | Not available | Unknown |
| ENSDARG00000070516 | si:dkeyp-52c3.2 | 4.74 | 3.86 | <0.001 | <0.001 | GTP binding | Unknown |
| ENSDARG00000070506 | CR450842.1 | 6.58 | 1.17 | <0.001 | <0.001 | Not available | Unknown |
| ENSDARG00000093998 | si:ch73-7i4.2 | −7.47 | 1.90 | <0.001 | <0.001 | Not available | Unknown |
| ENSDARG00000068621 | si:ch211-181d7.3 | 0.99 | 6.44 | <0.001 | <0.001 | Not available | Unknown |
| ENSDARG00000089831 | NLRP6 | −1.21 | 4.66 | <0.001 | <0.001 | Not available | Unknown |
| ENSDARG00000068621 | si:ch211-181d7.3 | 0.99 | 6.44 | <0.001 | <0.001 | Not available | Unknown |
| ENSDARG00000089582 | si:dkey-265e15.2 | 2.75 | 1.19 | <0.001 | <0.001 | Not available | Unknown |
| ENSDARG00000091847 | si:ch211-181d7.1 | 0.84 | 5.85 | <0.001 | 0.01 | ATP binding, nucleotide binding | Unknown |
This gene is associated with multiple categories. logFC, Log fold change; logCPM, Log count per million; FDR, False discovery rate. Human orthologs were found in Ensembl and categories assigned manually based on information available on Entrez gene, NGNC, and Omim databases. GO-terms were found in Zfin.
List of non-coding genes significantly affected in brains of zebrafish developmentally exposed to 3 ng/L (males) and 10 ng/L (females) EE.
| ENSDARG00000088865 | −3.62 | 5.46 | <0.001 | <0.001 | 5 | Unknown |
| ENSDARG00000088533 | −3.87 | 5.16 | <0.001 | <0.001 | 5 | Unknown |
| ENSDARG00000088976 | −3.54 | 3.17 | <0.001 | <0.001 | 5 | Unknown |
| ENSDARG00000087432 | −3.41 | 6.30 | <0.001 | <0.001 | 5 | Unknown |
| ENSDARG00000088430 | −3.34 | 4.26 | <0.001 | <0.001 | 5 | Unknown |
| ENSDARG00000087068 | −4.47 | 3.42 | <0.001 | <0.001 | 5 | Unknown |
| ENSDARG00000089384 | −3.42 | 2.91 | <0.001 | <0.001 | 20 | Unknown |
| ENSDARG00000086686 | −3.77 | 2.17 | <0.001 | <0.001 | 20 | Unknown |
| ENSDARG00000088510 | −2.61 | 4.08 | <0.001 | <0.001 | 5 | Unknown |
| ENSDARG00000084533 | −3.39 | 2.86 | <0.001 | <0.001 | 20 | Unknown |
| ENSDARG00000084962 | −2.78 | 2.46 | <0.001 | <0.001 | 20 | Unknown |
| ENSDARG00000090280 | −2.58 | 2.30 | <0.001 | <0.001 | 20 | Unknown |
| ENSDARG00000090175 | −3.33 | 4.74 | <0.001 | <0.001 | 5 | Unknown |
| ENSDARG00000091738 | −3.15 | 2.00 | <0.001 | <0.001 | 20 | Unknown |
| ENSDARG00000090733 | −3.66 | 2.16 | <0.001 | <0.001 | 5 | Unknown |
| ENSDARG00000088313 | −2.99 | 2.40 | <0.001 | 0.0035 | 20 | Unknown |
| ENSDARG00000088673 | −3.04 | 1.82 | <0.001 | 0.0190 | 20 | Unknown |
| ENSDARG00000087315 | −2.87 | 2.43 | <0.001 | 0.0425 | 20 | Unknown |
| ENSDARG00000088865 | −3.62 | 5.46 | <0.001 | <0.001 | 5 | Unknown |
| ENSDARG00000082087 | −1.18 | 5.75 | <0.001 | <0.001 | 7 | SNORD31 |
| ENSDARG00000082611 | −1.15 | 6.17 | <0.001 | <0.001 | 7 | SNORA23 |
| ENSDARG00000083108 | −1.25 | 5.64 | <0.001 | <0.001 | 20 | Yes, several |
| ENSDARG00000083400 | −0.81 | 6.17 | <0.001 | <0.001 | 20 | Yes, several |
| ENSDARG00000083784 | −1.34 | 4.65 | <0.001 | 0.0013 | 7 | SNORD22 |
| ENSDARG00000082008 | −2.22 | 5.61 | <0.001 | 0.0013 | 10 | SNORD14C |
| ENSDARG00000081115 | 1.11 | 8.63 | <0.001 | 0.0059 | 23 | Yes. several |
| ENSDARG00000080942 | −1.80 | 4.31 | <0.001 | 0.0071 | 2 | SNORD66 |
| ENSDARG00000081931 | −0.71 | 6.32 | <0.001 | 0.0086 | 19 | Yes, several |
| ENSDARG00000084828 | −0.91 | 7.09 | <0.001 | 0.0107 | 4 | Yes, several |
| ENSDARG00000081849 | −1.04 | 4.22 | <0.001 | 0.0112 | 1 | Yes, several |
| ENSDARG00000082928 | −1.16 | 4.38 | <0.001 | 0.0137 | 5 | Yes, several |
| ENSDARG00000084628 | −1.54 | 5.55 | <0.001 | 0.0251 | 20 | SNORA27 |
| ENSDARG00000083378 | −1.11 | 4.51 | <0.001 | 0.0327 | 5 | Yes, several |
| ENSDARG00000081235 | −0.77 | 6.73 | <0.001 | 0.0398 | 10 | SNORD14D |
| ENSDARG00000083063 | −1.29 | 6.19 | <0.001 | <0.001 | 8 | Unknown |
| ENSDARG00000083455 | −3.34 | 0.52 | <0.001 | 0.0024 | 4 | Yes, several |
| ENSDARG00000082472 | 4.33 | 8.56 | <0.001 | 0.0046 | 13 | Unkown |
| ENSDARG00000091828 | −6.47 | 5.23 | <0.001 | <0.001 | 5 | Yes, several |
| ENSDARG00000091776 | −5.69 | 4.92 | <0.001 | <0.001 | 5 | Yes, several |
| ENSDARG00000090705 | −5.03 | 5.21 | <0.001 | 0.0086 | 4 | Yes, 2 |
| ENSDARG00000083480 | −5.15 | 7.24 | <0.001 | <0.001 | MT | Unknown |
| ENSDARG00000082084 | −2.39 | 4.73 | <0.001 | 0.0135 | MT | Unknown |
| ENSDARG00000082753 | −1.68 | 11.74 | <0.001 | 0.0142 | MT | Unknown |
| ENSDARG00000091988 | −3.25 | 0.27 | <0.001 | 0.0196 | 19 | Unknown |
| ENSDARG00000096403 | −2.20 | 3.92 | <0.001 | <0.001 | 20 | Unknown |
| ENSDARG00000095598 | −1.39 | 2.68 | <0.001 | 0.0260 | 9 | Unknown |
| ENSDARG00000084661 | −1.54 | 4.36 | <0.001 | <0.001 | 2 | Unknown |
| ENSDARG00000080300 | 6.56 | 9.75 | <0.001 | 0.018 | 7 | Yes, several |
| ENSDARG00000084622 | 0.92 | 8.14 | <0.001 | 0.046 | 15 | Yes, several |
Human orthologs were found in Ensembl.
Figure 4Brain mRNA expression of (A) msmo1, (B) sqlea, (C) lss, and (D) hmgcs1 in zebrafish males developmentally exposed to 0 or 3 ng/L EE2 and remediated in clean water for 120 days. The mRNA expression was quantified with qPCR and normalized against the expression of 18S RNA and Elf1a, displaying the relative gene expression. Data represent mean ± 95% CI of 10 samples/group, *p < 0.05, **p < 0.01. *Significantly different from control group.